Senior international appointments at Schering-Plough

13 March 2006

As part of its intensified efforts to focus on Europe, Latin America and Asia-Pacific, US drug major Schering-Plough has announced the following appointments: Francesco Granata to group vice president, EUCAN Region I (Canada, Denmark, Finland, France, Germany, Ireland, Italy, Norway, Spain, Sweden and the UK); Bruno Strigini to group VP, EUCAN Region II (Austria, Belgium, Greece, the Netherlands, Portugal and Switzerland, as well as central and eastern Europe, the Middle East and Africa; Gilles Picard to VP and general manager, Schering-Plough France; Pierre Verstraete to group VP and president, Latin America Region; and Rodney Unsworth to group VP and president for the Asia-Pacific Regions (excluding Japan, where S-P's leadership continues under Masao Torii.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight